News
A type 2 diabetes drug, pioglitazone, may reduce the risk of prostate cancer relapse by targeting the PPARγ protein Prostate cancer patients with diabetes on PPARγ drugs had no relapse during ...
Actos is available as the generic drug pioglitazone. Generics usually cost less than brand-name drugs. Talk with your doctor if you’d like to know about taking generic pioglitazone.
Compared with pioglitazone, rosiglitazone produces unfavorable changes in plasma LDL-C, lipoprotein particles, and triglycerides. The 2 drugs are structurally different and may have different ...
Pioglitazone is the main TZD used to treat type 2 diabetes. It works by increasing your body’s sensitivity to insulin. Your doctor may prescribe it alone or along with metformin or other ...
Reason for posting: Pioglitazone is an oral hypoglycemic agent widely used as monotherapy or combination therapy for type 2 diabetes mellitus. However, a recent analysis by the drug's manufacturer of ...
Pioglitazone is one of two drugs known as thiazolidinediones, (TZDs) which are oral medications used to help with glycemic control and decreasing insulin resistance.
Researchers are saying the drug pioglitazone may help reduce the risk of dementia. The medication, sold under the brand name Actos, is prescribed to treat type 2 diabetes.
We randomly assigned 247 adults with nonalcoholic steatohepatitis and without diabetes to receive pioglitazone at a dose of 30 mg daily (80 subjects), vitamin E at a dose of 800 IU daily (84 ...
The diabetes drug pioglitazone may have a secondary role in helping smokers battle nicotine withdrawal symptoms as they try to kick the habit, according to new research.
Compared with other antidiabetic drugs, pioglitazone was associated with a 63% increased risk of bladder cancer (121 cases per 100,000 person-years vs 89 cases per 100,000 person-years; hazard ...
Hosted on MSN1mon
Can a Diabetes Drug Pioglitazone Fight Prostate Cancer Too? - MSNChennai, May 24 -- Highlights: * A type 2 diabetes drug, pioglitazone, may reduce the risk of prostate cancer relapse by targeting the PPAR (and) #947; protein ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results